Canadian Medical Marijuana & Cannabis Industry News

Aphria secures CA$100 million injection from anonymous investor

Canadian cannabis producer Aphria said Friday it has entered into an agreement with an institutional investor for a strategic investment worth 100 million Canadian dollars ($76 million). Chief Corporate Affairs Officer Tamara Macgregor told Marijuana Business Daily the investor requested to remain anonymous. The investor agreed to purchase just over 14 million Aphria units at CA$7.12 apiece. […]

Read More

Aurora Cannabis offshoot Australis Capital announces CFO departure

Australis Capital, an investment group that spun off from Canada’s Aurora Cannabis, announced the departure of Chief Financial Officer Michael Carlotti. In a brief news release issued after market close on Jan. 17, Las Vegas-based Australis said Carlotti’s employment had been “terminated” effective Jan. 16. The company gave no explanation for the move. Alex Han will […]

Read More

Aphria One, Brampton subsidiary receive EU-GMP certifications, clearing way for European cannabis exports

Aphria has received its first two essential European quality standard certifications, which the Canadian medical cannabis producer says will allow it to export finished dried flower and oil in bulk to European Union countries with established medical marijuana regimes. The company earned a certificate of EU-Good Manufacturing Practice (GMP) compliance on Jan. 15 for its […]

Read More

New Zealand to overturn cannabis vaporizer ban, clearing the way for imports

New Zealand plans to reverse a law banning cannabis vaporizers before new regulations kick in for the launch of the country’s medical program in April, Marijuana Business Daily has learned. “Currently, vaporizers are prohibited under the Misuse of Drugs (Prohibition of Cannabis Utensils and Methamphetamine Utensils) Notice,” a Health Ministry spokesperson told MJBizDaily. The “cabinet has […]

Read More

Week in Review: US lawmakers call for more marijuana research, some Cresco Lab employees in IL unionize, Trulieve addresses short sellers & more

U.S. lawmakers and experts tell a congressional panel that the federal government needs more cannabis research, some marijuana employees in Illinois vote to unionize, Trulieve refutes a short-seller report – and more of the week’s top MJ business news.   What’s the role of expanded marijuana research in federal reform? With strong bipartisan support, lawmakers […]

Read More

Analyst: Most Canadian marijuana firms not ready for next wave of products

The majority of Canadian cannabis companies were not ready for the launch of new cannabis products such as edibles, extracts and topicals, despite having more than a year to prepare for the Cannabis 2.0 era, according to an analyst. Only 10 companies had products available when Ontario’s only legal online store started selling the products […]

Read More

Product supply interruptions hit German medical cannabis market, but government dismisses risk of shortages

Supply disruptions are rippling through Germany’s growing medical cannabis market, but the country’s federal government says there are no signs at the moment of widespread product shortages. In response to a recent parliamentary inquiry, the government noted that pharmacies that sell medical cannabis have access to a variety of distributors beyond some companies whose products […]

Read More